Product Description: Deferitrin (GT-56-252), a desferrithiocin (DFT) analogue, is an orally active trident iron chelator. Deferitrin is used for chronic iron overload due to transfusional therapy. Deferitrin has the potential for beta-thalassemia major[1][2].
Applications: Neuroscience-Neuromodulation
Formula: C11H11NO4S
References: [1]Raymond J Bergeron, et al. Design, Synthesis, and Testing of Non-Nephrotoxic Desazadesferrithiocin Polyether Analogues. J Med Chem. 2008 Jul 10;51(13):3913-23./[2]Joanne M Donovan, et al. Preclinical and Clinical Development of Deferitrin, a Novel, Orally Available Iron Chelator. Ann N Y Acad Sci. 2005;1054:492-4.
CAS Number: 239101-33-8
Molecular Weight: 253.27
Compound Purity: 99.32
Research Area: Cardiovascular Disease
Solubility: DMSO : 125 mg/mL (ultrasonic)
Target: Others